mifepristone has been researched along with Metabolic Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brune, M; Bush, E; Chiou, W; Fung, S; Imade, H; Jacobson, P; Knourek-Segel, V; Kurukulasuriya, R; Link, JT; Monzon, K; Nguyen, PT; Shapiro, R; Stolarik, D; Wang, J; Wilcox, D; Yeh, VS | 1 |
| Hattori, T; Matsuura, N; Murohara, T; Nagasawa, K; Nagata, K; Takahashi, K; Takeshita, Y; Watanabe, S | 1 |
| Ito, S; Matsuura, N; Murohara, T; Nagasawa, K; Nagata, K; Sano, Y; Takeshita, Y; Uchinaka, A; Yamada, Y | 1 |
| Belanoff, JK; Blasey, CM; Gross, C; Roe, RL | 1 |
1 trial(s) available for mifepristone and Metabolic Syndrome
| Article | Year |
|---|---|
Mifepristone reduces weight gain and improves metabolic abnormalities associated with risperidone treatment in normal men.
Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Double-Blind Method; Hormone Antagonists; Humans; Hypothalamo-Hypophyseal System; Insulin; Male; Metabolic Syndrome; Mifepristone; Pituitary-Adrenal System; Receptors, Glucocorticoid; Reference Values; Risperidone; Triglycerides; Waist Circumference; Weight Gain; Young Adult | 2010 |
3 other study(ies) available for mifepristone and Metabolic Syndrome
| Article | Year |
|---|---|
Discovery of orally active butyrolactam 11beta-HSD1 inhibitors.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Administration, Oral; Animals; Humans; Lactams; Metabolic Syndrome; Mice | 2006 |
Blockade of glucocorticoid receptors with RU486 attenuates cardiac damage and adipose tissue inflammation in a rat model of metabolic syndrome.
Topics: Adipocytes; Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Gene Expression; Heart; Heart Diseases; Hormone Antagonists; Male; Metabolic Syndrome; Mifepristone; Panniculitis; Rats; Receptors, Glucocorticoid; Renin-Angiotensin System | 2015 |
Attenuation of cold stress-induced exacerbation of cardiac and adipose tissue pathology and metabolic disorders in a rat model of metabolic syndrome by the glucocorticoid receptor antagonist RU486.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adipose Tissue; Animals; Cold Temperature; Disease Models, Animal; Fibrosis; Glucose Intolerance; Heart; Hypertrophy, Left Ventricular; Male; Metabolic Syndrome; Mifepristone; Rats; Rats, Inbred Dahl; Rats, Zucker; Receptors, Glucocorticoid; Receptors, Leptin; Stress, Physiological | 2016 |